Search research articles
Contact Us
Filters
Showing results (21-30 of 25) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 25 results.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
August 2, 2022
<i>Nfkb2</i> deficiency and its impact on plasma cells and immunoglobulin expression in murine small intestinal mucosa
Stamatia Papoutsopoulou, Joseph Tang, Ahmed H Elramli, et al.
Frontiers in Immunology
|
October 2, 2019
Macrophage-Specific NF-κB Activation Dynamics Can Segregate Inflammatory Bowel Disease Patients
Stamatia Papoutsopoulou, Michael D Burkitt, François Bergey, et al.
Pharmacology & Therapeutics
|
January 31, 2017
Towards better models and mechanistic biomarkers for drug-induced gastrointestinal injury
Daniel F Carr, Seyoum Ayehunie, Andrea Davies, et al.
Gut
|
April 19, 2020
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
Nicholas A Kennedy, Gareth-Rhys Jones, Christopher A Lamb, et al.
The Lancet. Gastroenterology & Hepatology
|
February 25, 2024
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial
Nurulamin M Noor, James C Lee, Simon Bond, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 25) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 25 results.
American Journal of Physiology. Gastrointestinal and Liver Physiology
|
August 2, 2022
<i>Nfkb2</i> deficiency and its impact on plasma cells and immunoglobulin expression in murine small intestinal mucosa
Stamatia Papoutsopoulou, Joseph Tang, Ahmed H Elramli, et al.
Frontiers in Immunology
|
October 2, 2019
Macrophage-Specific NF-κB Activation Dynamics Can Segregate Inflammatory Bowel Disease Patients
Stamatia Papoutsopoulou, Michael D Burkitt, François Bergey, et al.
Pharmacology & Therapeutics
|
January 31, 2017
Towards better models and mechanistic biomarkers for drug-induced gastrointestinal injury
Daniel F Carr, Seyoum Ayehunie, Andrea Davies, et al.
Gut
|
April 19, 2020
British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic
Nicholas A Kennedy, Gareth-Rhys Jones, Christopher A Lamb, et al.
The Lancet. Gastroenterology & Hepatology
|
February 25, 2024
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial
Nurulamin M Noor, James C Lee, Simon Bond, et al.
Page
of 3